Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Jun 1;181(6):2141–2151. doi: 10.1084/jem.181.6.2141

Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter [published erratum appears in J Exp Med 1995 Oct 1;182(4):1177]

PMCID: PMC2192050  PMID: 7760003

Abstract

The mechanisms that regulate the commitment of a totipotent stem cell to the megakaryocytic lineage are largely unknown. Using a molecular approach to the study of megakaryocytopoiesis and platelet production, mice in which thrombocytopoiesis could be controlled were produced by targeting the expression of the herpes simplex virus thymidine kinase toxigene to megakaryocytes using the regulatory region of the gene encoding the alpha subunit of the platelet integrin alpha IIb beta 3. The programmed eradication of the megakaryocytic lineage was induced by treating transgenic mice bearing the hybrid construct (alpha IIbtk) with the antiherpetic drug ganciclovir (GCV). After 10 d of treatment, the platelet number was reduced by > 94.6%. After discontinuing GCV, the bone marrow was repopulated with megakaryocytes and the platelet count was restored within 7 d. Prolonged GCV treatment induced erythropenia in the transgenic mice. Assays of myeloid progenitor cells in vitro demonstrated that the transgene was expressed in early erythro- megakaryocytic progenitor cells. The reversibility and facility of this system provides a powerful model to determine both the critical events in megakaryocytic and erythroid lineage development and for evaluating the precise role that platelets play in the pathogenesis of a number of vascular occlusive disorders.

Full Text

The Full Text of this article is available as a PDF (3.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berridge M. V., Ralph S. J., Tan A. S. Cell-lineage antigens of the stem cell-megakaryocyte-platelet lineage are associated with the platelet IIb-IIIa glycoprotein complex. Blood. 1985 Jul;66(1):76–85. [PubMed] [Google Scholar]
  2. Berthier R., Valiron O., Schweitzer A., Marguerie G. Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: role of TGF beta. Stem Cells. 1993 Mar;11(2):120–129. doi: 10.1002/stem.5530110207. [DOI] [PubMed] [Google Scholar]
  3. Borrelli E., Heyman R., Hsi M., Evans R. M. Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7572–7576. doi: 10.1073/pnas.85.20.7572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown G., Bunce C. M., Lord J. M. Models of haemopoiesis. Leuk Res. 1990;14(6):495–499. doi: 10.1016/0145-2126(90)90001-p. [DOI] [PubMed] [Google Scholar]
  5. Burton F. H., Hasel K. W., Bloom F. E., Sutcliffe J. G. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature. 1991 Mar 7;350(6313):74–77. doi: 10.1038/350074a0. [DOI] [PubMed] [Google Scholar]
  6. Culver K. W., Ram Z., Wallbridge S., Ishii H., Oldfield E. H., Blaese R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992 Jun 12;256(5063):1550–1552. doi: 10.1126/science.1317968. [DOI] [PubMed] [Google Scholar]
  7. Debili N., Kieffer N., Mitjavila M. T., Villeval J. L., Guichard J., Teillet F., Henri A., Clemetson K. J., Vainchenker W., Breton-Gorius J. Expression of platelet glycoproteins by erythroid blasts in four cases of trisomy 21. Leukemia. 1989 Sep;3(9):669–678. [PubMed] [Google Scholar]
  8. Eisel U., Reynolds K., Riddick M., Zimmer A., Niemann H., Zimmer A. Tetanus toxin light chain expression in Sertoli cells of transgenic mice causes alterations of the actin cytoskeleton and disrupts spermatogenesis. EMBO J. 1993 Sep;12(9):3365–3372. doi: 10.1002/j.1460-2075.1993.tb06010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fauser A. A., Messner H. A. Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts. Blood. 1979 May;53(5):1023–1027. [PubMed] [Google Scholar]
  10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  11. Fong A. M., Santoro S. A. Transcriptional regulation of alpha IIb integrin gene expression during megakaryocytic differentiation of K562 cells. Role of a silencer element. J Biol Chem. 1994 Jul 15;269(28):18441–18447. [PubMed] [Google Scholar]
  12. Fraser J. K., Leahy M. F., Berridge M. V. Expression of antigens of the platelet glycoprotein IIb/IIIa complex on human hematopoietic stem cells. Blood. 1986 Sep;68(3):762–769. [PubMed] [Google Scholar]
  13. Gurney A. L., Carver-Moore K., de Sauvage F. J., Moore M. W. Thrombocytopenia in c-mpl-deficient mice. Science. 1994 Sep 2;265(5177):1445–1447. doi: 10.1126/science.8073287. [DOI] [PubMed] [Google Scholar]
  14. Heidenreich R., Eisman R., Surrey S., Delgrosso K., Bennett J. S., Schwartz E., Poncz M. Organization of the gene for platelet glycoprotein IIb. Biochemistry. 1990 Feb 6;29(5):1232–1244. doi: 10.1021/bi00457a020. [DOI] [PubMed] [Google Scholar]
  15. Heyman R. A., Borrelli E., Lesley J., Anderson D., Richman D. D., Baird S. M., Hyman R., Evans R. M. Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2698–2702. doi: 10.1073/pnas.86.8.2698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen F. S. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994 Jun 16;369(6481):568–571. doi: 10.1038/369568a0. [DOI] [PubMed] [Google Scholar]
  17. Leary A. G., Ogawa M., Strauss L. C., Civin C. I. Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. J Clin Invest. 1984 Dec;74(6):2193–2197. doi: 10.1172/JCI111645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lemarchandel V., Ghysdael J., Mignotte V., Rahuel C., Roméo P. H. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol. 1993 Jan;13(1):668–676. doi: 10.1128/mcb.13.1.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Levin J., Ebbe S. Why are recently published platelet counts in normal mice so low? Blood. 1994 Jun 15;83(12):3829–3831. [PubMed] [Google Scholar]
  20. Lindner V., Fingerle J., Reidy M. A. Mouse model of arterial injury. Circ Res. 1993 Nov;73(5):792–796. doi: 10.1161/01.res.73.5.792. [DOI] [PubMed] [Google Scholar]
  21. Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Heipel M. D., Burkhead S. K., Kramer J. M. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994 Jun 16;369(6481):565–568. doi: 10.1038/369565a0. [DOI] [PubMed] [Google Scholar]
  22. Long M. W., Williams N. Immature Megakaryocytes in the Mouse: Morphology and quantitation by acetylcholinesterase staining. Blood. 1981 Nov;58(5):1032–1039. [PubMed] [Google Scholar]
  23. Marguerie G. A., Thomas-Maison N., Ginsberg M. H., Plow E. F. The platelet-fibrinogen interaction. Evidence for proximity of the A alpha chain of fibrinogen to platelet membrane glycoproteins IIb/III. Eur J Biochem. 1984 Feb 15;139(1):5–11. doi: 10.1111/j.1432-1033.1984.tb07968.x. [DOI] [PubMed] [Google Scholar]
  24. Martin D. I., Zon L. I., Mutter G., Orkin S. H. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 1990 Mar 29;344(6265):444–447. doi: 10.1038/344444a0. [DOI] [PubMed] [Google Scholar]
  25. McDonald T. P., Sullivan P. S. Megakaryocytic and erythrocytic cell lines share a common precursor cell. Exp Hematol. 1993 Sep;21(10):1316–1320. [PubMed] [Google Scholar]
  26. McLeod D. L., Shreeve M. M., Axelrad A. A. Chromosome marker evidence for the bipotentiality of BFU-E. Blood. 1980 Aug;56(2):318–322. [PubMed] [Google Scholar]
  27. Messner H. A., Jamal N., Izaguirre C. The growth of large megakaryocyte colonies from human bone marrow. J Cell Physiol Suppl. 1982;1:45–51. doi: 10.1002/jcp.1041130410. [DOI] [PubMed] [Google Scholar]
  28. Milanesi G., Barbanti-Brodano G., Negrini M., Lee D., Corallini A., Caputo A., Grossi M. P., Ricciardi R. P. BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli. Mol Cell Biol. 1984 Aug;4(8):1551–1560. doi: 10.1128/mcb.4.8.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Molla A., Andrieux A., Chapel A., Schweitzer A., Berthier R., Marguerie G. Lack of transcription and expression of the alpha IIb integrin in human early haematopoietic stem cells. Br J Haematol. 1992 Dec;82(4):635–639. doi: 10.1111/j.1365-2141.1992.tb06937.x. [DOI] [PubMed] [Google Scholar]
  30. Moolten F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 1986 Oct;46(10):5276–5281. [PubMed] [Google Scholar]
  31. Nakahata T., Ogawa M. Clonal origin of murine hemopoietic colonies with apparent restriction to granuclocyte-macrophage-megakaryocyte (GMM) differentiation. J Cell Physiol. 1982 Jun;111(3):239–246. doi: 10.1002/jcp.1041110304. [DOI] [PubMed] [Google Scholar]
  32. Nakahata T., Spicer S. S., Ogawa M. Clonal origin of human erythro-eosinophilic colonies in culture. Blood. 1982 Apr;59(4):857–864. [PubMed] [Google Scholar]
  33. Nishi N., Nakahata T., Koike K., Takagi M., Naganuma K., Akabane T. Induction of mixed erythroid-megakaryocyte colonies and bipotential blast cell colonies by recombinant human erythropoietin in serum-free culture. Blood. 1990 Oct 1;76(7):1330–1335. [PubMed] [Google Scholar]
  34. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993 Jun 1;81(11):2844–2853. [PubMed] [Google Scholar]
  35. Okumura N., Tsuji K., Nakahata T. Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood. 1992 Aug 1;80(3):642–650. [PubMed] [Google Scholar]
  36. Palmiter R. D., Behringer R. R., Quaife C. J., Maxwell F., Maxwell I. H., Brinster R. L. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell. 1987 Jul 31;50(3):435–443. doi: 10.1016/0092-8674(87)90497-1. [DOI] [PubMed] [Google Scholar]
  37. Phillips D. R., Charo I. F., Scarborough R. M. GPIIb-IIIa: the responsive integrin. Cell. 1991 May 3;65(3):359–362. doi: 10.1016/0092-8674(91)90451-4. [DOI] [PubMed] [Google Scholar]
  38. Plump A. S., Smith J. D., Hayek T., Aalto-Setälä K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992 Oct 16;71(2):343–353. doi: 10.1016/0092-8674(92)90362-g. [DOI] [PubMed] [Google Scholar]
  39. Prandini M. H., Uzan G., Martin F., Thevenon D., Marguerie G. Characterization of a specific erythromegakaryocytic enhancer within the glycoprotein IIb promoter. J Biol Chem. 1992 May 25;267(15):10370–10374. [PubMed] [Google Scholar]
  40. Ravid K., Beeler D. L., Rabin M. S., Ruley H. E., Rosenberg R. D. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1521–1525. doi: 10.1073/pnas.88.4.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Romeo P. H., Prandini M. H., Joulin V., Mignotte V., Prenant M., Vainchenker W., Marguerie G., Uzan G. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature. 1990 Mar 29;344(6265):447–449. doi: 10.1038/344447a0. [DOI] [PubMed] [Google Scholar]
  42. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  43. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  44. Suda J., Suda T., Ogawa M. Analysis of differentiation of mouse hemopoietic stem cells in culture by sequential replating of paired progenitors. Blood. 1984 Aug;64(2):393–399. [PubMed] [Google Scholar]
  45. Suda T., Suda J., Ogawa M. Single-cell origin of mouse hemopoietic colonies expressing multiple lineages in variable combinations. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6689–6693. doi: 10.1073/pnas.80.21.6689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Thompson C. B., Love D. G., Quinn P. G., Valeri C. R. Platelet size does not correlate with platelet age. Blood. 1983 Aug;62(2):487–494. [PubMed] [Google Scholar]
  47. Tronik D., Dreyfus M., Babinet C., Rougeon F. Regulated expression of the Ren-2 gene in transgenic mice derived from parental strains carrying only the Ren-1 gene. EMBO J. 1987 Apr;6(4):983–987. doi: 10.1002/j.1460-2075.1987.tb04848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tsuji K., Nakahata T. Stochastic model for multipotent hemopoietic progenitor differentiation. J Cell Physiol. 1989 Jun;139(3):647–653. doi: 10.1002/jcp.1041390327. [DOI] [PubMed] [Google Scholar]
  49. Uzan G., Prenant M., Prandini M. H., Martin F., Marguerie G. Tissue-specific expression of the platelet GPIIb gene. J Biol Chem. 1991 May 15;266(14):8932–8939. [PubMed] [Google Scholar]
  50. Wagner M. J., Sharp J. A., Summers W. C. Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1441–1445. doi: 10.1073/pnas.78.3.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Warden C. H., Hedrick C. C., Qiao J. H., Castellani L. W., Lusis A. J. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993 Jul 23;261(5120):469–472. doi: 10.1126/science.8332912. [DOI] [PubMed] [Google Scholar]
  52. Wendling F., Maraskovsky E., Debili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 1994 Jun 16;369(6481):571–574. doi: 10.1038/369571a0. [DOI] [PubMed] [Google Scholar]
  53. al-Shawi R., Burke J., Wallace H., Jones C., Harrison S., Buxton D., Maley S., Chandley A., Bishop J. O. The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter. Mol Cell Biol. 1991 Aug;11(8):4207–4216. doi: 10.1128/mcb.11.8.4207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. de Sauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wong S. C., Kuang W. J. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994 Jun 16;369(6481):533–538. doi: 10.1038/369533a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES